P1116: SAFETY, PHARMACOKINETIC (PK), PHARMACODYNAMIC (PD) AND ACTIVITY OF THE HIGHLY SELECTIVE PHOSPHOINOSITIDE 3-KINASE INHIBITOR DELTA (PI3KΔ) INHIBITOR IOA-244 IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL)

• C. Carlostella,
• M. Lahn,
• T. Hammett,
• L. van der Veen,
• Z. Johnson,
• C. Pickering,
• A. Santoro

Affiliations

C. Carlostella

1 IRCSS Humanitas Research Hospital, Milan, Italy

M. Lahn

2 iOnctura, Geneva, Switzerland

T. Hammett

2 iOnctura, Geneva, Switzerland

L. van der Veen

2 iOnctura, Geneva, Switzerland

Z. Johnson

2 iOnctura, Geneva, Switzerland

C. Pickering

2 iOnctura, Geneva, Switzerland

A. Santoro

1 IRCSS Humanitas Research Hospital, Milan, Italy